Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide in Early Parkinson's Disease
NCT04305002Phase 2Unknown
- Sponsor
- Center for Neurology, Stockholm
- Start
- Jan 2020
- Primary completion
- Oct 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of exenatide in Parkinson's disease (PD), sponsored by Center for Neurology, Stockholm. Status: unknown.
02
Drugs
exenatide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04305002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04305002.